Inhibitory effect of antisense miR-30a-5p on glioma cell growth in vivo
10.3760/cma.j.issn.1673-422X.2013.02.021
- VernacularTitle:反义miR-30a-5p抑制脑胶质瘤生长的体内实验研究
- Author:
Jikui SUN
;
Zhifan JIA
;
Peiyu PU
;
Guangxiu WANG
;
Anling ZHANG
;
Weidong YANG
- Publication Type:Journal Article
- Keywords:
Gliomas;
Oligonucleotides,antisense;
Drug therapy;
miR-30a-5p
- From:
Journal of International Oncology
2013;(2):149-152
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the inhibitory effect of knocking down miR-30a-5p on the U87 human glioma xenograft growth and its possible mechanism.Methods Nude mice bearing subcutaneous U87 human glioblastoma were established and separated into three groups (eight for each group) by randomized digital table method,including control group,scr-ODN treated group and AS-miR-30a-5p treated group.After relevant subcutaneous injection treatment,tumor size was measured every other day until the observation period ended.Researchers executed the animals after the treatment,stripped tumor tissues and extracted RNA and protein.Real-time PCR was conducted to detect the expression of miR-30a-5p.The histopathological characteristics and proliferation and apoptosis biological characters (including SEPT7,PCNA,cyclin D1,MMP-2,apoptosis related factor P53,bcl-2 and caspase3) were evaluated by HE and immunohistochemical staining,Westem blot analysis respectively,and the cell apoptosis was detected by TUNEL method.Results In AS-miR-30a-5p treated group,the tumor growth was delayed and the final tumor volume was smaller than that in the control and scr-ODN treated group (F =7.167,P ＜0.05),and the expression of miR-30a-5p was knocked down.The expression of PCNA,cyclin D1 were significantly downregulated while P53,SEPT7 and caspase3 up-regulated.Apoptotic index was increased significantly.Conclusion As-miR-30a-5p suppresses the growth of U87 human gliomas xenografts significantly.Malignant phenotype of tumors are reversed to a considerable degree.Therefore,miR-30a-5p can be a candidate for targeted therapy of human glioma.
